Antiviral agents are a class of medications designed to inhibit the replication of viruses, preventing their spread within the body. These agents target specific stages of the viral life cycle, such as viral entry, genome replication, or protein synthesis. Common antiviral drug classes include nucleoside/nucleotide analogs, protease inhibitors, polymerase inhibitors, and neuraminidase inhibitors. Antiviral agents are crucial in the treatment of viral infections, including influenza, herpes, HIV, hepatitis, and respiratory viruses. They can either directly interfere with viral replication or stimulate the immune system's response to eliminate infected cells. Antiviral therapy has been particularly significant in managing chronic viral infections like HIV, allowing individuals to lead healthier lives. The development of antiviral agents has also played a pivotal role in controlling and preventing viral outbreaks. While antiviral agents have demonstrated effectiveness, challenges include the emergence of drug-resistant viral strains and potential side effects. Ongoing research focuses on the discovery of new antiviral drugs, understanding viral resistance mechanisms, and exploring combination therapies to enhance efficacy and reduce the risk of resistance.
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya